Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | MBTD1 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-08 |
mRNA | PGAP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | PLCB2 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
mRNA | RALGDS | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
mRNA | SNX20 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-08 |
mRNA | NLRP3 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
mRNA | AC138969.4 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | NAPB | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
mRNA | GRK2 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-08 |